Geron | GERN - Ebit

Stock Price
1.66
Daily Change
0.08 4.75%
Monthly
-8.06%
Yearly
-4.89%
Q1 Forecast
1.53

Geron reported $-10.79M in EBIT for its fiscal quarter ending in December of 2025.





Ebit Change Date
Amgen USD 3.96B 464M Dec/2025
Bio Techne USD 54.46M 6.8M Dec/2025
Cassava Sciences USD -11.86M 33.53M Sep/2025
Cytokinetics USD -178.37M 11.61M Dec/2025
Esperion Therapeutics USD 85.23M 95.19M Dec/2025
Exelixis USD 235.91M 20.45M Dec/2025
Genmab DKK 432M 900.27M Jun/2025
Geron USD -10.79M 3.1M Dec/2025
Gilead Sciences USD 2.96B 551M Dec/2025
Incyte USD 383.88M 47.44M Dec/2025
MacroGenics USD 20.16M 55.51M Sep/2025
Novartis USD -9.19B 13.87B Jun/2025
Novavax USD -134.02M 49.55M Sep/2024